Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nikoloz Gongadze"'
Autor:
Tamar Kezeli, Nikoloz Gongadze, Galina Sukoyan, Marina Shikhashvili, Zaza Chapichadze, Maia Okujava, Nino Dolidze
Publikováno v:
Journal of Circadian Rhythms, Vol 17, Iss 1 (2019)
The purpose of this study was to evaluate the relationship between the circadian profile of the vasorelaxing substances calcitonin gene-related peptide (CGRP) and epoxyeicosatrienoic acids (EETs) and the vasconstrictive agent endothelin-1 (ET1) and t
Externí odkaz:
https://doaj.org/article/03a50a94b47e40a1a743981b46a29d6b
Publikováno v:
EXPERIMENTAL & CLINICAL MEDICINE GEORGIA.
Autor:
DAVID GOLOSHVILI, ZURAB ZAALISHVILI, DIANA KERATISHVILI, MAIA OKUJAVA, NIKOLOZ GONGADZE, MANANA GHONGHADZE
Publikováno v:
EXPERIMENTAL & CLINICAL MEDICINE GEORGIA.
Publikováno v:
EXPERIMENTAL & CLINICAL MEDICINE GEORGIA.
Autor:
Nino N. Dolidze, Marina Shikhashvili, Nikoloz Gongadze, Maia Okujava, Tamar Kezeli, Galina Sukoyan, Zaza Z. Chapichadze
Publikováno v:
Journal of Circadian Rhythms; Vol 17 (2019); 10
Journal of Circadian Rhythms
Journal of Circadian Rhythms, Vol 17, Iss 1 (2019)
Journal of Circadian Rhythms
Journal of Circadian Rhythms, Vol 17, Iss 1 (2019)
The purpose of this study was to evaluate the relationship between the circadian profile of the vasorelaxing substances calcitonin gene-related peptide (CGRP) and epoxyeicosatrienoic acids (EETs) and the vasconstrictive agent endothelin-1 (ET1) and t
Autor:
Tamari Rukhadze, M. Chipashvili, Nino M. Dolidze, Tamar Kezeli, Nikoloz Gongadze, Makrine Mirziashvili, Galina Sukoyan
Publikováno v:
The EPMA Journal
Background Anti-ischemic effects of NO releasing by nitroglycerin (NTG) and the release of calcitonin gene-related peptide (CGRP) are involved in the decrease of vascular remodeling in different cardiovascular diseases. Using a nitrate-free period is
Autor:
Merab M. Dvali, Irakli I. Margvelashvili, Edisher E. Tsivtsivadze, Nikoloz Gongadze, T. Kezeli, Galina Sukoyan, Zaza Z. Chapichadze, Shota S. Jibuti, Nino N. Dolidze
Publikováno v:
Clinical Therapeutics. 37:e68